Every year brings changes to the skilled nursing industry, and operators entered 2025 with many new elements on their plate.

rate for its next-generation sequencing (NGS)-based clonoSEQ® test for minimal – or measurable – residual disease (MRD) assessment is now in effect as of January 1, SEATTLE, Jan. 02 ...

Flatiron Health and Exact Sciences collaborate to use Flatiron's platform for rapid data analysis with the Oncodetect MRD test ... diverse patient groups; to do so, they will reach patients ...

(RTTNews) - Adaptive Biotechnologies Corp. (ADPT), Tuesday announced a partnership with NeoGenomics, Inc. (NEO), an oncology testing services company, to advance minimal residual disease or MRD ...

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies. Denise Appleby is a freelance writer. The opinions expressed ...

A bill introduced to the New York state Senate is seeking to bolster the disclosures that reverse mortgage lenders make to ...

Avoiding any penalties is often the most valuable thing you can do. RMD mistakes can be costly, and they're more likely to happen when you plan to reinvest your distribution. Retirement accounts ...

Arnab Basu, MD, MPH, FACP, discusses circulating tumor DNA (ctDNA) tests with high sensitivity and specificity.

Pairing Adaptive Biotechnologies’ clonoSEQ MRD results with NeoGenomics’ COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment ...

We explain how fines work for late returns and missed payments, and offer advice on what to do if you're struggling to pay Matthew JenkinSenior writer The deadline for filing your 2023-24 ...